Companies / Immunomic Therapeutics
Immunomic Therapeutics
United States
Immunomic Therapeutics develops vaccines through its proprietary technology platform, UNITE, which is designed to utilize the body's natural biochemistry to develop vaccines that generate broad immune responses
Immunomic Therapeutics, based in United States, has 1 investor on file, among them LSG Investments. Its site was last checked 12 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from LSG Investments
18 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (90%), Industrial & Manufacturing (5%), Consumer (5%).
See LSG Investments' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Immunomic Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when LSG Investments adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/immunomix.com/investors
# also
GET /v1/companies/immunomix.com
GET /v1/companies/immunomix.com/news